Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     



This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Google Scholar
Right arrow Articles by Lichtenfels, R.
Right arrow Articles by Seliger, B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lichtenfels, R.
Right arrow Articles by Seliger, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on March 27, 2009
Revised on September 8, 2009
Accepted on September 14, 2009

Systematic comparative protein expression profiling of clear cell renal cell carcinoma: A pilot study based on the separation of tissue specimen by two-dimensional electrophoresis

Rudolf Lichtenfels, Sven P Dressler, Monica Zobawa, Christian V Recktenwald, Angelika Ackermann, Derek Atkins, Michael Kersten, Andrea Hesse, Maria Puttkammer, Friedrich Lottspeich, and Barbara Seliger

Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle (Saale) 06112

Corresponding Author: Barbara.Seliger{at}medizin.uni-halle.de

Proteome-based technologies represent powerful tools for the analysis of protein expression profiles including the identification of potential cancer candidate biomarkers. Thus, we here provide a comprehensive protein expression map for clear cell renal cell carcinoma established by systematic comparative two-dimensional gel electrophoresis based protein expression profiling of 16 paired tissue systems comprised of ccRCC lesions and corresponding tumor-adjacent renal epithelium using overlapping narrow pH gradients. This approach led to the mapping of 348 distinct spots corresponding to 248 different protein identities. By implementing restriction criteria concerning their detection frequency and overall regulation mode 28 up- and 56 downregulated single target spots were considered as potential candidate biomarkers. Based on their gene ontology information these differentially expressed proteins were classified into distinct functional groups and according to their cellular distribution. Moreover three representative members of this group namely calbindin, gelsolin and H-FABP were selected and their expression pattern analyzed by immunohistochemistry using tissue microarrays. Thus, this pilot study provides a significant update of the current RCC map and defines a number of differentially expressed proteins but both their potential as candidate biomarkers and clinical relevance has to be further explored in tissues and for body fluids like serum or urine.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement